Kyorin Pharmaceutical Co.,ltd.TSE: 4569

KYORIN Pharmaceutical: Sales and operating profit rose, but net profit and comprehensive income fell sharply year-over-year

· Issued by Kyorin Pharmaceutical Co.,ltd.

Net sales and operating profit grew year-over-year for the nine months ended December 31, 2024, but profit attributable to owners of parent and comprehensive income declined sharply. Full-year guidance projects continued sales growth but lower net profit.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis